Clinical Trial: LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07246005) titled 'LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus' on Oct. 17.

Brief Summary: The LVT DURATION (Optimal Duration of Anticoagulation for LV Thrombus) is a pilot study planned to assess the practicalities of conducting a randomised control trial (RCT) whilst establishing data around the ideal duration of anticoagulation in the treatment of LV thrombus. The main objectives of the study are:

* To assess the practicalities of conducting an RCT with regard to recruitment, retention, and outcome measurement.

* To identify the optimal length of anticoagulation in the treatment of LV Thrombus

After random...